Vanguard International High Dividend Yield ETF

VYMI

Börsenwert 21,6 Mrd. $

The Vanguard International High Dividend Yield ETF buys global stocks it believes will outperform for the next 30 years. This dividend ETF holds a diversified portfolio of 1,567 stocks.

VYM has dominated income portfolios for years, but its international counterpart has quietly outpaced it across multiple recent time horizons while putting more cash in shareholders' pockets.

Vanguard International High Dividend Yield ETF (VYMI) is rated Buy, driven by sector catalysts in financials, energy, and healthcare supporting dividend growth and capital appreciation. VYMI outperforms peers with a 5-year average annual return of 14.13%, a 3.61% dividend yield, and attractive valuation metrics (P/E 13.6x, P/B 1.8x). Key holdings like HSBC, Royal Bank of Canada, Roche, Novartis, and Shell provide resilience, growth, and sustainable dividends, reinforcing VYMI's competitive positioning.

The Buy survived an adverse setup: US growth rebounded hard, yet VYMI still delivered positive absolute returns with the value rotation staying structurally intact throughout. The delivered Fed hike confirms higher-for-longer, compressing long-duration US growth multiples while rewarding VYMI's short-duration value tilt, especially its heavy financials weighting. Currency, not a broken thesis, drove most of the S&P lag; that drag is now fading as euro weakness plateaus and the yen stays capped.

I screen U.S.-listed dividend growth stocks with 2–6% yields, strong revenue growth, and disciplined payout ratios, targeting undervalued opportunities. The final 8-stock portfolio spans Energy, Financials, Materials, Consumer Discretionary, Healthcare, and Industrials, with a weighted yield of 3.79% and 5-year dividend growth of 20.92% with a factor weight. Portfolio construction emphasizes forward P/E below 20, price to cash flow between 5x–10x, and mid/large caps with proven top-line expansion.

IDV has delivered income investors a reliable yield for years, but a rival international dividend ETF with a fraction of the fees quietly outpaced it over the last 12 months, and the gap raises real questions about what concentration and

Vanguard International High Dividend Yield ETF is a buy at $105.60, despite a 19.7% YTD gain, due to robust financials exposure. VYMI's 43.6% allocation to financials aligns with rising global rates and improving bank earnings, supporting the current investment thesis. Compared to SCHY, VYMI delivers superior total returns without sacrificing yield, and its sector concentration is offset by broad company diversification.

Vanguard runs a nearly identical sibling to VYM outside US borders, and most income investors have never heard of it despite the fact that it has quietly beaten the famous original on both yield and price return over the past

Vanguard has cemented itself as one of the biggest names in exchange-traded funds (ETFs). The investment advisory firm and global asset manager briefly surpassed BlackRock NYSE: BLK as the largest U.S. ETF provider by assets.

The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) has become the default income sleeve for millions of American portfolios, but its international sibling barely registers with the same audience.